Clinical Consulting K/S: Financial statements 2020
CVR: 38863797
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Clinical Consulting K/S (CVR 38863797) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,680,129 and a net result of DKK -21,576 compared with DKK -113,581 the year before. That is an increase of 6.5% compared with the year before. The profit margin was -1.3%. Equity in the 2020 report amounted to DKK 172,396. The solvency ratio was 95.7%.
- Revenue
- DKK 1,680,129
- Gross Profit
- DKK 1,515,865
- Profit/Loss
- DKK -21,576
- Equity
- DKK 172,396
- Total Assets
- DKK 180,063
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 1.7M | 1.5M | -22K | 172K | - |
| 2019 | 1.6M | 1.4M | -114K | 194K | - |
Official annual report
How creditworthy is Clinical Consulting K/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Clinical Consulting K/S has published its annual report for 2019. Revenue came to DKK 1,577,852, and the net result was DKK -113,581.
About Clinical Consulting K/S
Clinical Consulting K/S was a Danish company of the type Kommanditselskab based in Farum, founded in 2017. The company has been dissolved on 6 February 2025. The company was registered under the industry Virksomhedsrådgivning og andre rådgivningsaktiviteter. In 2023, the company reported revenue of DKK 969,972 and a net result of DKK 33,551 compared with DKK 56,087 the year before. Equity in the 2023 report amounted to DKK 309,940.
